Influence of Lymphatic, Microvascular and Perineural Invasion on Oncological Outcome in Patients with Neuroendocrine Tumors of the Small Intestine

被引:0
|
作者
Butz, Frederike [1 ,2 ,3 ]
Dukaczewska, Agata [1 ,2 ,3 ]
Kunze, Catarina Alisa [2 ,3 ,4 ]
Kroemer, Janina Maren [1 ,2 ,3 ]
Reinhard, Lisa [1 ,2 ,3 ]
Jann, Henning [2 ,3 ,5 ]
Fehrenbach, Uli [2 ,3 ,6 ]
Mueller-Debus, Charlotte Friederieke [1 ,2 ,3 ]
Skachko, Tatiana [1 ,2 ,3 ]
Pratschke, Johann [1 ,2 ,3 ]
Goretzki, Peter E. [1 ,2 ,3 ]
Mogl, Martina T. [1 ,2 ,3 ]
Dobrindt, Eva Maria [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Campus Virchow Klinikum, Campus Charite Mitte, Dept Surg, D-10117 Berlin, Germany
[2] Free Univ Berlin, D-10117 Berlin, Germany
[3] Humboldt Univ, D-10117 Berlin, Germany
[4] Charite Univ Med Berlin, Dept Pathol, D-10117 Berlin, Germany
[5] Charite Univ Med Berlin, Campus Virchow Klinikum, Campus Charite Mitte, Dept Hepatol & Gastroenterol, D-10117 Berlin, Germany
[6] Charite Univ Med Berlin, Dept Radiol, D-10117 Berlin, Germany
关键词
small-intestinal neuroendocrine tumors; microvascular invasion; lymphatic invasion; perineural invasion; oncological outcome; PROGNOSTIC-FACTORS; VENOUS INVASION; SURVIVAL; SURGERY; DEATH;
D O I
10.3390/cancers16020305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For the histopathological work-up of resected neuroendocrine tumors of the small intestine (siNET), the determination of lymphatic (LI), microvascular (VI) and perineural (PnI) invasion is recommended. Their association with poorer prognosis has already been demonstrated in many tumor entities. However, the influence of LI, VI and PnI in siNET has not been sufficiently described yet. A retrospective analysis of all patients treated for siNET at the ENETS Center of Excellence Charit & eacute;-Universit & auml;tsmedizin Berlin, from 2010 to 2020 was performed (n = 510). Patients who did not undergo primary resection or had G3 tumors were excluded. In the entire cohort (n = 161), patients with LI, VI and PnI status had more distant metastases (48.0% vs. 71.4%, p = 0.005; 47.1% vs. 84.4%, p < 0.001; 34.2% vs. 84.7%, p < 0.001) and had lower rates of curative surgery (58.0% vs. 21.0%, p < 0.001; 48.3% vs. 16.7%, p < 0.001; 68.4% vs. 14.3%, p < 0.001). Progression-free survival was significantly reduced in patients with LI, VI or PnI compared to patients without. This was also demonstrated in patients who underwent curative surgery. Lymphatic, vascular and perineural invasion were associated with disease progression and recurrence in patients with siNET, and these should therefore be included in postoperative treatment considerations.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] A Predictive Nomogram for Small Intestine Neuroendocrine Tumors (NETS)
    Kelly, Susheian
    Aalberg, Jeffrey
    Kim, Michelle
    Divino, Celia
    PANCREAS, 2019, 48 (03) : 441 - 441
  • [22] Tumors of the small intestine: Presentation, treatment, and outcome
    Carpenter, S.
    James, A.
    Eckford, J. E.
    Sullivan, J. P.
    Thomas, J. S.
    Ashley, P.
    Shabahang, M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 104 - 104
  • [23] Predicting Resectability of Primary Tumor and Mesenteric Lumps in Patients with Small Intestine Neuroendocrine Tumors
    Piccioli, A. N.
    Funicelli, L.
    Fazio, N.
    Borin, S.
    Petz, W.
    Spinoglio, G.
    Bertani, E.
    NEUROENDOCRINOLOGY, 2018, 106 : 283 - 283
  • [24] ASSOCIATION OF MICROVASCULAR AND CAPILLARY-LYMPHATIC INVASION WITH OUTCOME FOR PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING NEPHRECTOMY
    Eisenberg, Manuel S.
    Cheville, John C.
    Thompson, R. Houston
    Kaushik, Dharam
    Lohse, Christine
    Boorjian, Stephen A.
    Costello, Brian A.
    Leibovich, Bradley C.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E300 - E300
  • [25] Multiple Gastric G1 Neuroendocrine Tumors with Venous and Lymphatic Invasion
    Tatsuta, Tetsuya
    Yoshimura, Tetsuro
    Hasui, Keisuke
    Takasugi, Kaori
    Sawaya, Manabu
    Hanabata, Norihiro
    Shimoyama, Tadashi
    Kijima, Hiroshi
    Fukuda, Shinsaku
    INTERNAL MEDICINE, 2013, 52 (15) : 1697 - 1701
  • [26] Is a centralization of surgical treatment for neuroendocrine tumors of the small intestine meaningful?
    Manoharan, Jerena
    Bartsch, Detlef K.
    CHIRURGIE, 2024, : 307 - 308
  • [27] Tumor Heterogeneity in Small Intestine Neuroendocrine Tumors Metastatic to the Liver
    Shi, Chanjuan
    Hande, Kenneth
    Walker, Ronald
    Sandlers, Martin
    Berlin, Jordan
    Liu, Eric
    PANCREAS, 2014, 43 (03) : 504 - 504
  • [28] MicroRNA Signatures as Novel Biomarkers in Small Intestine Neuroendocrine Tumors
    Li, Su-Chen
    Martijn, Cecile
    Essaghir, Ahmed
    Lloyd, Ricardo V.
    Demoulin, JeanBaptiste
    Oberg, Kjell
    Giandomenico, Valeria
    PANCREAS, 2012, 41 (02) : 340 - 340
  • [29] Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases
    Imperiale, Alessio
    Poncet, Gilles
    Addeo, Pietro
    Ruhland, Elisa
    Roche, Colette
    Battini, Stephanie
    Cicek, A. Ercument
    Chenard, Marie Pierrette
    Hervieu, Valerie
    Goichot, Bernard
    Bachellier, Philippe
    Walter, Thomas
    Namer, Izzie Jacques
    METABOLITES, 2019, 9 (12)
  • [30] Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine
    Polydorides, Alexandros D.
    Liu, Qingqing
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (04) : 547 - 556